Browsing by Author "Doroshuk, Marissa L."
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- ItemOpen AccessMotivations for use, user experience, and quality of menstrual cycle tracking mobile applications: A scoping review protocol(2023-07-05) Kazakoff, Alissa; Doroshuk, Marissa L.; Ganshorn, Heather; Doyle-Baker, Patricia K.Objective: This scoping review aims to comprehensively assess and describe the existing peerreviewed literature on motivations for use, user experience, and menstrual cycle app quality. Introduction: The global mHealth market is growing at an unprecedented rate and is expected to reach an estimated value of $18.7 billion by 2030 (Prophecy Market Insights, 2021). Tracking health and menstrual cycle metrics can empower individuals by increasing awareness and understanding of their menstrual cycle, being prepared for different cycle phases, contraception and fertility, improving health-related behaviours, and informing conversations with healthcare providers (Epstein et al., 2017; Levy & Romo-Avilés 2019; Karasneh et al., 2020; Adnan et al., 2021; Gonçalves et al., 2021). Recent studies have identified several different factors that render users more likely for continued app use. These include perceived personal and health benefits, app accuracy, usability, and user-friendly design (Karasneh et al, 2020; Schantz et al., 2021). Inclusion criteria: This scoping review will investigate the existing literature on menstrual cycle tracking app use and factors contributing to user retention, such as motivations for the use of the app, user experience, and app quality. All studies published in English after 2010 will be included related to investigating apps that serve a pre-menopausal menstrual cycle app user base, given that relevant data may be included even in studies where the scoping review research question is not the focus. Methods: The search strategy will aim to locate peer-reviewed studies. An initial limited search of MEDLINE was undertaken to identify articles on the topic. Studies published in English will be included. Studies published since 2010 will be included as that timeline is most appropriate for the introduction of smartphones and smartphone apps on the market. The databases to be searched include MEDLINE (Ovid platform), Embase (Ovid platform), Scopus (Elsevier), ACM Digital Library, and IEEE Xplore.
- ItemOpen AccessSalivary and urinary methodology for ovulation and menstrual cycle phase detection among eumenorrheic females: A scoping review protocol(2022-05-03) Doroshuk, Marissa L.; Kazakoff, Alissa; Hayden, K. Alix; Doyle-Baker, Patricia K.Most females will experience variability in their menstrual cycle (MC) at some point across the reproductive lifespan (Bull et al., 2019). Current literature suggests that it is important for females to track MC regularity and ovulation occurrence as it is related to other health outcomes (Lynch et al., 2014). MC tracking and ovulation can be detected using a variety of methods (Allen et al., 2017). The gold standard for ovulation detection includes daily transvaginal ultrasonography and laparoscopic evaluation of the developing follicle until the point of rupture. These methods, however, can be costly, invasive, and have a large participant burden (Allen et al., 2017; Lynch et al., 2014). Therefore, accessible, and reliable methods of ovulation and MC phase detection are warranted. The study objective is to examine methods in the literature associated with salivary assay and urinary hormone testing for ovulation and menstrual cycle phase detection. Inclusion criteria for participants and defining characteristics consist of the following a) eumenorrheic females between 18 to 45 years of age, b) salivary and/or urinary hormone testing methods, c) menstrual cycle measurement, d) ovulation detection, and e) estradiol, progesterone, and/or luteinizing hormone (LH) measures. The proposed scoping review will be conducted in accordance with the JBI methodology for scoping reviews described in the JBI Manual for Evidence Synthesis (2020). The review will also cover the 2018 PRISMA reporting items for scoping review extensions (Tricco et al., 2018). Population: Eumenorrheic Females. Concept: Salivary and Urinary Hormone Testing Methods. Context: Ovulation and Menstrual Cycle Phase Detection PRIMARY QUESTION: What is the validity and reliability of salivary and urinary assay testing for female sex hormones in ovulation detection and menstrual cycle phase identification? SECONDARY QUESTION: What are the salivary and urinary protocols used to test female sex hormones and what ranges are considered within normal? TERTIARY QUESTION: Are salivary and urinary assays for female sex hormones (estrogen, progesterone, and luteinizing hormone) comparable to the gold standard, serum, in relation to the menstrual cycle?"